Stefano Ponzano
European Medicines Agency(NL)
Publications by Year
Research Areas
Cannabis and Cannabinoid Research, Peroxisome Proliferator-Activated Receptors, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Synthetic Organic Chemistry Methods
Most-Cited Works
- → Advances in the discovery of N-acylethanolamine acid amidase inhibitors(2014)60 cited
- → Synthesis and Structure–Activity Relationship (SAR) of 2-Methyl-4-oxo-3-oxetanylcarbamic Acid Esters, a Class of Potent N-Acylethanolamine Acid Amidase (NAAA) Inhibitors(2013)46 cited
- → An Important Role for N-Acylethanolamine Acid Amidase in the Complete Freund’s Adjuvant Rat Model of Arthritis(2016)44 cited
- → β-Lactones Inhibit N-acylethanolamine Acid Amidase by S-Acylation of the Catalytic N-Terminal Cysteine(2012)37 cited
- → Synthesis, Structure–Activity, and Structure–Stability Relationships of 2‐Substituted‐N‐(4‐oxo‐3‐oxetanyl) N‐Acylethanolamine Acid Amidase (NAAA) Inhibitors(2014)30 cited
- → Promoting Safe Early Clinical Research of Novel Drug Candidates: A European Union Regulatory Perspective(2017)28 cited
- → Activity-Based Probe for N-Acylethanolamine Acid Amidase(2015)27 cited
- → Potent α-amino-β-lactam carbamic acid ester as NAAA inhibitors. Synthesis and structure–activity relationship (SAR) studies(2016)27 cited
- → A European regulatory perspective on cystic fibrosis: current treatments, trends in drug development and translational challenges for CFTR modulators(2018)22 cited
- → Discovery and SAR Evolution of Pyrazole Azabicyclo[3.2.1]octane Sulfonamides as a Novel Class of Non-Covalent N-Acylethanolamine-Hydrolyzing Acid Amidase (NAAA) Inhibitors for Oral Administration(2021)20 cited